INTRODUCTION: Angiomyolipomas (AML) are rare benign renal tumours which are associated with aneurysms that can cause haemorrhage. Embolisation of AML greater than 4 cm with a variety of embolic agents is now the first-line treatment in these cases. METHODS: This was a retrospective analysis of all patients who underwent AML embolisation at Beaumont Hospital from 2000 to 2006 to review the efficacy of embolisation in the treatment of AMLs. RESULTS: There were six patients in total (n = 6). One patient (16%) had a background of tuberous sclerosis. Half of the patients presented acutely with bleeding and abdominal pain (50%) while the other half were found incidentally. There were no mortalities overall and three patients (50%) developed post embolisation syndrome. Five patients (83%) had a good response to embolisation with no further growth or regression of the AML. CONCLUSION: Embolisation is a safe and effective method for treating patients with AML.
INTRODUCTION:Angiomyolipomas (AML) are rare benign renal tumours which are associated with aneurysms that can cause haemorrhage. Embolisation of AML greater than 4 cm with a variety of embolic agents is now the first-line treatment in these cases. METHODS: This was a retrospective analysis of all patients who underwent AML embolisation at Beaumont Hospital from 2000 to 2006 to review the efficacy of embolisation in the treatment of AMLs. RESULTS: There were six patients in total (n = 6). One patient (16%) had a background of tuberous sclerosis. Half of the patients presented acutely with bleeding and abdominal pain (50%) while the other half were found incidentally. There were no mortalities overall and three patients (50%) developed post embolisation syndrome. Five patients (83%) had a good response to embolisation with no further growth or regression of the AML. CONCLUSION: Embolisation is a safe and effective method for treating patients with AML.
Authors: C Tallarigo; R Baldassarre; G Bianchi; L Comunale; G Olivo; M Pea; F Bonetti; G Martignoni; G Zamboni; G Mobilio Journal: J Urol Date: 1992-12 Impact factor: 7.450